+

WO1990005520A3 - Traitement antiviral de cultures de tissus et compositions - Google Patents

Traitement antiviral de cultures de tissus et compositions Download PDF

Info

Publication number
WO1990005520A3
WO1990005520A3 PCT/US1989/005022 US8905022W WO9005520A3 WO 1990005520 A3 WO1990005520 A3 WO 1990005520A3 US 8905022 W US8905022 W US 8905022W WO 9005520 A3 WO9005520 A3 WO 9005520A3
Authority
WO
WIPO (PCT)
Prior art keywords
tissue culture
compositions
processes
antiviral processes
culture antiviral
Prior art date
Application number
PCT/US1989/005022
Other languages
English (en)
Other versions
WO1990005520A2 (fr
Inventor
Edward Shanbrom
Original Assignee
Edward Shanbrom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edward Shanbrom filed Critical Edward Shanbrom
Publication of WO1990005520A2 publication Critical patent/WO1990005520A2/fr
Publication of WO1990005520A3 publication Critical patent/WO1990005520A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

On décrit des substances nutritives, telles que le sérum de veau f÷tal, pour les milieux de culture de tissus, comprenant un sérum et un ou plusieurs composés triterpenoïdes glycyrrhiziques, capables d'inactiver le cytomégalovirus (CMV), le virus de diarrhée bovine (BVD) et autres virus spécifiques, ainsi que des procédés permettant de protéger lesdites cultures de tissus des infections virales.
PCT/US1989/005022 1988-11-23 1989-11-08 Traitement antiviral de cultures de tissus et compositions WO1990005520A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27611388A 1988-11-23 1988-11-23
US276,113 1988-11-23

Publications (2)

Publication Number Publication Date
WO1990005520A2 WO1990005520A2 (fr) 1990-05-31
WO1990005520A3 true WO1990005520A3 (fr) 1990-07-12

Family

ID=23055226

Family Applications (6)

Application Number Title Priority Date Filing Date
PCT/US1989/005025 WO1990005547A1 (fr) 1988-11-23 1989-11-08 Procede de traitement antiviral du sperme
PCT/US1989/005023 WO1990005533A1 (fr) 1988-11-23 1989-11-08 Albumine biologiquement competente, capable d'inactiver un virus
PCT/US1989/005024 WO1990005546A1 (fr) 1988-11-23 1989-11-08 Amelioration du procede antiviral d'echantillonnage de sang et son appareil
PCT/US1989/005021 WO1990005550A1 (fr) 1988-11-23 1989-11-08 Traitement antiviral applique aux organes de transplantation
PCT/US1989/005022 WO1990005520A2 (fr) 1988-11-23 1989-11-08 Traitement antiviral de cultures de tissus et compositions
PCT/US1989/005117 WO1990005548A1 (fr) 1988-11-23 1989-11-13 Procede et produit sanguin d'inactivation d'un virus

Family Applications Before (4)

Application Number Title Priority Date Filing Date
PCT/US1989/005025 WO1990005547A1 (fr) 1988-11-23 1989-11-08 Procede de traitement antiviral du sperme
PCT/US1989/005023 WO1990005533A1 (fr) 1988-11-23 1989-11-08 Albumine biologiquement competente, capable d'inactiver un virus
PCT/US1989/005024 WO1990005546A1 (fr) 1988-11-23 1989-11-08 Amelioration du procede antiviral d'echantillonnage de sang et son appareil
PCT/US1989/005021 WO1990005550A1 (fr) 1988-11-23 1989-11-08 Traitement antiviral applique aux organes de transplantation

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/US1989/005117 WO1990005548A1 (fr) 1988-11-23 1989-11-13 Procede et produit sanguin d'inactivation d'un virus

Country Status (5)

Country Link
US (4) US4891221A (fr)
EP (2) EP0399027A1 (fr)
JP (2) JPH03503287A (fr)
AU (6) AU4636589A (fr)
WO (6) WO1990005547A1 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112804A (en) * 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
US5248501A (en) * 1988-11-22 1993-09-28 Parnell Pharmaceuticals Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith
US5128132A (en) * 1988-11-22 1992-07-07 Parnell Pharmaceuticals, Inc. Eriodictyon compositions and methods for treating internal mucous membranes
US5156973A (en) * 1988-11-23 1992-10-20 Edward Shanbrom Antiviral blood sampling process and apparatus
US5149718A (en) * 1989-01-19 1992-09-22 New York University Biological fluid purification system
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
EP0530216A4 (en) * 1990-04-19 1993-06-30 Medimmune, Inc. Administration of monoclonal antibodies against respiratory viruses
ATE175123T1 (de) * 1990-07-19 1999-01-15 Us Commerce Verbesserte immunotherapeutische methode zur verhinderung oder behandlung viraler krankheiten der atemwege
US5316768A (en) * 1990-12-28 1994-05-31 Murdock International Corporation Pharmaceutical compositions having antiviral activity against human cytomegalovirus
US5290540A (en) * 1991-05-01 1994-03-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method for treating infectious respiratory diseases
USRE37525E1 (en) 1991-05-01 2002-01-22 Henry M. Jackson Foundation Method for treating infectious respiratory diseases
US5356880A (en) * 1991-05-30 1994-10-18 Sanwa Kagaku Kenkyusho Co., Ltd. Glycyrrhetinic acid derivatives
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US6207107B1 (en) 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
US5591350A (en) * 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
US5797871A (en) * 1994-08-19 1998-08-25 Lifenet Research Foundation Ultrasonic cleaning of allograft bone
US5556379A (en) * 1994-08-19 1996-09-17 Lifenet Research Foundation Process for cleaning large bone grafts and bone grafts produced thereby
US5977034A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Composition for cleaning bones
US5976104A (en) * 1994-08-19 1999-11-02 Lifenet Research Foundation Recirculation method for cleaning essentially intact bone grafts using pressure mediated flow of solutions and bone grafts produced thereby
US5760189A (en) * 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
GB9517622D0 (en) * 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
TW505653B (en) * 1996-02-26 2002-10-11 Meiji Seika Co Triterpene derivatives possessing an effect of treating liver diseases and pharmacentical compositions containing the same
US5881720A (en) * 1997-04-29 1999-03-16 The Procter & Gamble Company Method of delivering halotherapy
US5916919A (en) * 1997-06-27 1999-06-29 Dalhousie University Retrovirus protease inhibitors
US6045787A (en) * 1998-09-01 2000-04-04 Shanbrom Technologies Llc Protection of labile proteins during iodine disinfection
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6323183B1 (en) * 1999-06-02 2001-11-27 Ornella Flore Composition for and method of treatment using triterpenoids
FI113942B (fi) * 2000-08-18 2004-07-15 Control Ox Oy Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin
TWI282275B (en) * 2000-08-17 2007-06-11 Control Ox Oy Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
AU2002308648A1 (en) * 2001-05-04 2002-11-18 Theralife, Inc. Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
EP1397149A1 (fr) * 2001-06-18 2004-03-17 S.A.V Virex Co Ltd Extrait de nerium oleander, compositions contenant cet extrait de nerium oleander l. et procede permettant de preparer cet extrait
US20030163147A1 (en) * 2002-02-22 2003-08-28 Rabiner Robert A. Apparatus and method for using a vascular introducer with an ultrasonic probe
EP2324838A1 (fr) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions comprenant du diméthylsulfoxyde
US7955418B2 (en) 2005-09-12 2011-06-07 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
ITRM20060163A1 (it) * 2006-03-24 2007-09-25 Ist Farmacoterapico It Spa Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
US20080124395A1 (en) * 2006-06-22 2008-05-29 Weiliam Chen Formulations and devices for treatment or prevention of neural ischemic damage
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US9839609B2 (en) * 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
RU2429227C1 (ru) * 2010-04-08 2011-09-20 Учреждение Российской академии наук Институт технической химии Уральского отделения РАН АЦЕТИЛГИДРАЗОН 1-ЦИАНО-19β,28-ЭПОКСИ-2,3-СЕКО-18α-ОЛЕАН-3-АЛЯ, ПРОЯВЛЯЮЩИЙ ИНГИБИРУЮЩУЮ АКТИВНОСТЬ В ОТНОШЕНИИ ВИРУСА ВЕЗИКУЛЯРНОГО СТОМАТИТА ШТАММ "ИНДИАНА"
WO2012019991A1 (fr) * 2010-08-09 2012-02-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés et compositions pharmaceutiques pour le traitement des infections par le vih-1
WO2012026928A1 (fr) * 2010-08-25 2012-03-01 Diacarta Llc Utilisation d'acide glycyrrhétinique, d'acide glycyrrhizique et de composés associés pour prévention et/ou traitement de fibrose pulmonaire
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
EP2726606A1 (fr) * 2011-06-28 2014-05-07 Leukocare Ag Nouveau procédé de stabilisation pour des virus ou bactéries
WO2013023362A1 (fr) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 Immunoglobuline dirigée contre le cytomégalovirus humain pour injection intraveineuse et son procédé de préparation
WO2016086060A1 (fr) * 2014-11-26 2016-06-02 The J. David Gladstone Institutes Procédés pour traiter une infection à cytomégalovirus
WO2017177966A1 (fr) * 2016-04-15 2017-10-19 正大天晴药业集团股份有限公司 Préparation à inhaler d'acide isoglycyrrhizique ou d'un sel de celui-ci et utilisation dans la préparation de médicaments pour traiter des maladies du système respiratoire
EP3888662A1 (fr) * 2020-04-02 2021-10-06 Vossensteyn Composés, compositions et dispositifs destinés à être utilisés dans le traitement d'infections à coronavirus
EP4216975A4 (fr) * 2020-09-25 2024-09-04 Laila Nutraceuticals Compositions à base de plantes synergiques pour l'immunité, le rhume et la toux
MX2021005280A (es) 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140809A (en) * 1983-06-01 1984-12-05 Biorex Laboratories Ltd New derivatives of glycyrrhetinic acid
EP0249557A1 (fr) * 1986-06-12 1987-12-16 Fondation Centre National De Transfusion Sanguine Milieu de culture comportant de l'albumine humaine, procédé de préparation d'un produit injectable à partir de ce milieu, produit obtenu et son utilisation, composition obtenue
EP0255420A2 (fr) * 1986-07-26 1988-02-03 Minophagen Pharmaceutical Company Agent antiviral d'inhibition de la croissance du virus du syndrome immuno-deficitaire acquis (SIDA)
DE3733181C1 (de) * 1987-10-01 1989-01-19 Biotest Pharma Gmbh Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390683A (en) * 1972-12-18 1975-04-16 Biorex Laboratories Ltd Pharmaceutical composition
GB1555796A (en) * 1976-10-15 1979-11-14 Unilever Ltd Composition for treating acne
US4699789A (en) * 1985-09-27 1987-10-13 Eastern Artificial Insemination Cooperative, Inc. Viral free semen and methods of producing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140809A (en) * 1983-06-01 1984-12-05 Biorex Laboratories Ltd New derivatives of glycyrrhetinic acid
EP0249557A1 (fr) * 1986-06-12 1987-12-16 Fondation Centre National De Transfusion Sanguine Milieu de culture comportant de l'albumine humaine, procédé de préparation d'un produit injectable à partir de ce milieu, produit obtenu et son utilisation, composition obtenue
EP0255420A2 (fr) * 1986-07-26 1988-02-03 Minophagen Pharmaceutical Company Agent antiviral d'inhibition de la croissance du virus du syndrome immuno-deficitaire acquis (SIDA)
DE3733181C1 (de) * 1987-10-01 1989-01-19 Biotest Pharma Gmbh Verfahren zur Herstellung eines hochreinen,virussicheren,biologisch aktiven Transferrinpraeparates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 106, No. 13, 15 March 1987, (Columbus, Ohio, US), D.J. DARGAN et al.: "The Antiviral Activity against Herpes Simplex Virus of the Triterpenoid Compounds Carbenoxolone Sodium and Cicloxolone Sodium", see page 26 *Abstract 95655m & J. Antimicrob. Chemother. 1986, 1, (Suppl. B), 185-200* *

Also Published As

Publication number Publication date
AU4525089A (en) 1990-06-12
AU4664989A (en) 1990-06-12
AU4653989A (en) 1990-06-12
EP0406369A1 (fr) 1991-01-09
EP0399027A1 (fr) 1990-11-28
WO1990005546A1 (fr) 1990-05-31
AU4750390A (en) 1990-06-12
US5128149A (en) 1992-07-07
AU4525289A (en) 1990-06-12
US4891221A (en) 1990-01-02
WO1990005550A1 (fr) 1990-05-31
JPH03503170A (ja) 1991-07-18
WO1990005547A1 (fr) 1990-05-31
JPH03503287A (ja) 1991-07-25
US5128150A (en) 1992-07-07
AU4636589A (en) 1990-06-12
WO1990005533A1 (fr) 1990-05-31
WO1990005548A1 (fr) 1990-05-31
WO1990005520A2 (fr) 1990-05-31
US4933169A (en) 1990-06-12

Similar Documents

Publication Publication Date Title
WO1990005520A3 (fr) Traitement antiviral de cultures de tissus et compositions
CA2173328A1 (fr) Inhibiteurs de la protease du vih
CA2250078A1 (fr) Procedes de replication des virus de la grippe dans une culture cellulaire, et virus de la grippe obtenus selon ce procede
MY107843A (en) Anti-viral compounds.
DK410681A (da) Fremgangsmaade til fremstilling af amidin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
AU1442183A (en) Heat treatment of blood plasma to reduce infectivity of micro-organisms
AU8125694A (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
CA2130360A1 (fr) Derives de l'acide sulfonique pour le traitement des maladies virales
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
IE902138L (en) Monokine activity interference
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
EP0357958A3 (en) Pharmaceutical preparation against viral diseases comprising a liver extract
Zajac et al. Autogenous and virus-induced interferons from lines of lymphoblastoid cells
AU5064985A (en) Methods and compositions for treating viral infection
JO1610B1 (en) Tetrahydimidimidose compounds (1,4) benzodiazepine-2 thyonath anti-viral and anti-viral
MD960172A (en) 5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
IE781315L (en) Virus cultivation
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
CA2071954A1 (fr) Cellules fixees sur un substrat et methode de production de virus/antigenes viraux
PT88430A (pt) Vecteur d'expression des proteines du virus hiv-2 un agent causal du sida culture cellulaire infectee ou transformee par ce vecteur procede de preparation de proteines et d'un vaccin et anticorps obtenus
EP0316592A3 (fr) 3'-Fluoro-2',3'-didéoxyuridine, et ses application thérapeutique
EP0244211A3 (fr) Procédé pour la propagation en masse de tissu de plantes in vitro

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载